Galcanezumab is a humanized IgG4 monoclonal antibody targeting the CGRP ligand, which binds to the ligand calcitonin gene-related peptide. Galcanezumab can be used to prevent and treat migraines or cluster headaches.
CAS Number:
[1578199-75-3]
Target:
LY 2951742
* VAT and and shipping costs not included. Errors and price changes excepted